We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ultrasis | LSE:ULT | London | Ordinary Share | GB0001494979 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.095 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Dec 2019 to Dec 2024
TIDMULT
RNS Number : 9657I
Ultrasis PLC
31 March 2015
Ultrasis plc
("Ultrasis" or the "Company")
Suspension of trading in the Company's shares.
As announced on 17 March 2015, the Company has posted a circular to shareholders with regards a proposed Fundraising that comprises a Subscription for New Ordinary Shares, Open Offer of New Ordinary Shares and New Facility Agreement. In aggregate, the Fundraising and New Facility will raise up to GBP5.375 million
The Circular also included details of a Share Capital Reorganisation, Waiver of obligation under Rule 9 of the City Code on Takeovers and Mergers and Change of Name to 365 Health Solutions plc. The Fundraising cannot proceed without Independent Shareholder consent being obtained to approve the Waiver.
The proposed Fundraising and refinancing is significantly reliant upon Mr Paul Bell, Ultrasis's largest shareholder. The Company remains reliant on Mr Bell to meet its future working capital needs, but has not been able to confirm with absolute certainty if Mr Bell remains able to proceed with the proposed Fundraising.
As a result, the Directors believe that, without the additional funding that would be made available to the Company via the Proposals or any other material injection of funds, the Company will not have sufficient funds to enable it to continue to trade. Accordingly, the Directors of the Company have requested suspension of its shares pending clarification of its financial position and the ability of Mr Bell to proceed with the proposed Fundraising.
The shareholder meeting to approve the proposed refinancing is scheduled for 14 April 2015.
The Company will update shareholders as further information becomes available.
Unless otherwise defined, all capitalised terms in this announcement shall have the meaning given to them in the Circular, which was posted to shareholders on 17 March 2015 and details of which were announced on that date
For all enquiries please contact:
Ultrasis plc Tel: +44 (0) 20 7535 2050 John Smith, Interim Executive Chairman finnCap Ltd Geoff Nash/Simon Hicks Tel: +44 (0) 20 7220 0500
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCZMGFFNMZGKZG
1 Year Ultrasis Chart |
1 Month Ultrasis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
